Sisunatovir

DB15674InvestigationalSmall molecule

Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV).

Formula / weight: C₂₃H₂₂F₄N₄O · 446.45 g/mol (avg)
Code names: RV-521

Resolves to

Compound

UNIIKE63TTO7WKCAS1903763-82-5

Structure

InChIKeyJOPCJJSYRPUEDS-UHFFFAOYSA-NSMILESNCC1=CC2=C(C=C1)N(CCCC(F)(F)F)C(CN1C(=O)C3(CC3)C3=C1C=C(F)C=C3)=N2

Targets

P03420F

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Sisunatovir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account